Yuya Nakatani

Yuya Nakatani

Auto-generated profile, based on publicly available information

Yuya Nakatani

Oral and Maxillofacial Surgery, Dry Mouth Clinic, The Nippon Dental University Niigata Hospital, Niigata, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2018 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
SOSeigo Ohba
Seigo Ohba
YSYoshinori Sumita
Yoshinori Sumita
YNYuya Nakatani
Yuya Nakatani
SNSawako Noda
Sawako Noda
Izumi AsahinaIzumi Asahina
Izumi Asahina

29 May 2025 in Dentomaxillofacial Radiology
Verified
Journal Article
Closed access
ASAi Shirai
Ai Shirai
YNYuya Nakatani
Yuya Nakatani
STShuji Toya
Shuji Toya
IOIchiro Ogura
Ichiro Ogura
Objective: The aim of this study was to investigate MR sialography and SPECT/CT for parotid glands in Sjögren’s syndrome patients. Methods: Thirty Sjögren’s syndrome patients underwent MR sialography and SPECT/CT. The MR sialographic stagings of Sjögren’s syndrome were determined by the criteria (stage 0: normal; stage 1: punctate appearance; stage 2: globular appearance; stage 3: cavitary appearance; stage 4: destructive appearance). The maximum standardized uptake value (SUVmax) of the right and left parotid glands with SPECT/CT was obtained using a workstation and software. MR sialographic stagings and SUVmax of parotid glands were evaluated at pre- and post-stimulation and ratio of pre- to post-stimulation. Results: Regarding pre-stimulation, the SUVmax of stage 0 (31.9 ± 19.3) was significantly higher than that of stage 2 (19.7 ± 7.5, P = .046), stage 3 (10.2 ± 7.1, P < .001) and stage 4 (6.8 ± 4.3, P < .001). Furthermore, the SUVmax at ratio of pre- to post-stimulation of stage 0 (1.87 ± 0.55) was significantly higher than that of stage 3 (1.16 ± 0.30, P = .001) and stage 4 (1.16 ± 0.40, P < .001). Conclusion: This study suggests that MR sialography and SPECT/CT SUV are effective tool for the management of Sjögren’s syndrome patients.

14 January 2025 in Oral Science International
Verified
Journal Article
Closed access
ASAi Shirai
Ai Shirai
RORuri Ogawa
Ruri Ogawa
YTYasuhito Tezuka
Yasuhito Tezuka
YNYuya Nakatani
Yuya Nakatani
STShuji Toya
Shuji Toya
IOIchiro Ogura
Ichiro Ogura